Of JAKs, STATs, blind watchmakers, jeeps and trains

被引:69
作者
Kerr, IM
Costa-Pereira, AP
Lillemeier, BF
Strobl, B
机构
[1] Canc Res UK London Res Inst, Lincolns Inn Labs, London WC2A 3PX, England
[2] Stanford Univ, Sch Med, Beckman Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA
[3] Inst Anim Breeding & Genet, A-1210 Vienna, Austria
关键词
interferon-gamma; interleukin-6; receptor chimeras; Janus kinase/signal transducer and activator of transcription signalling; signal transducer and activator of transcription-1; green fluorescent protein;
D O I
10.1016/S0014-5793(03)00411-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling is essential but not sufficient for full responses to the interferons (IFNs), most cytokines and some growth factors. The IFN-gamma and interleukin-6 (IL-6) response pathways have been used as model systems to investigate both the signals involved and their organisation. Activated STAT1 diffuses freely in the cytoplasmic and nuclear compartments of the cell providing a 'random walk' element in the IFN-gamma response. Completely foreign chimeric receptors and, remarkably, in the absence of STAT3, the endogenous IL-6 receptor can efficiently mediate an IFN-gamma-like response. Accordingly all of the signals required for an IFN-gamma response can be generated through physiological levels of a foreign ligand. JAK/STAT signalling, therefore, appears 'soft-wired', modular and highly flexible with substantial overlap between different response pathways. The data are consistent with a generic or 'core' set of signals from JAK/receptor complexes with 'add-on' modulation through specific receptor motifs. The cellular background likely profoundly affects the nature of the response. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V.. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 39 条
[1]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[2]   MODULATION OF MURINE AND HUMAN INTERFERON-GAMMA RECEPTOR EXPRESSION BY THEIR LIGANDS OR PHORBOL ESTER [J].
BADER, T ;
WIETZERBIN, J .
CYTOKINE, 1994, 6 (01) :70-78
[3]   Dynamic behavior of transcription factors on a natural promoter in living cells [J].
Becker, M ;
Baumann, C ;
John, S ;
Walker, DA ;
Vigneron, M ;
McNally, JG ;
Hager, GL .
EMBO REPORTS, 2002, 3 (12) :1188-1194
[4]   Cytoplasmic transport of Stat3 by receptor-mediated endocytosis [J].
Bild, AH ;
Turkson, J ;
Jove, R .
EMBO JOURNAL, 2002, 21 (13) :3255-3263
[5]   Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state [J].
Briscoe, J ;
Rogers, NC ;
Witthuhn, BA ;
Watling, D ;
Harpur, AG ;
Wilks, A ;
Stark, GR ;
Ihle, JN ;
Kerr, IM .
EMBO JOURNAL, 1996, 15 (04) :799-809
[6]   Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons [J].
Burfoot, MS ;
Rogers, NC ;
Watling, D ;
Smith, JM ;
Pons, S ;
Paonessaw, G ;
Pellegrini, S ;
White, MF ;
Kerr, IM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) :24183-24190
[7]   STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation [J].
Chung, JK ;
Uchida, E ;
Grammer, TC ;
Blenis, J .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6508-6516
[8]   Mutational switch of an IL-6 response to an interferon-γ-like response [J].
Costa-Pereira, AP ;
Tininini, S ;
Strobl, B ;
Alonzi, T ;
Schlaak, JF ;
Is'harc, H ;
Gesualdo, I ;
Newman, SJ ;
Kerr, IM ;
Poli, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8043-8047
[9]  
DAMELL JE, 1994, SCIENCE, V264, P1415
[10]   A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor [J].
Dittrich, E ;
Haft, CR ;
Muys, L ;
Heinrich, PC ;
Graeve, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5487-5494